https://www.selleckchem.com/pr....oducts/enarodustat.h
ce interval 0.44-0.88), p for effect = 0.007, I2 = 36%. Conclusion The use of levosimendan on adult patients with cardiogenic shock may facilitate the veno-arterial extracorporeal membrane oxygenation weaning and reduce all-cause mortality. Few articles of this topic are available, and prospective, randomized multi-center trials are warranted to conclude decisively on the benefits of levosimendan in this setting.The present study is aimed at understanding how trans masculine and nonbinary individuals describe aspects of their sexual
Curtir
Comentario
Compartilhar
